Primary Site >> Colorectal Cancer
Gene >> MAGEB6
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. PMID: 17692977 Ref: Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Rad PMID: 17906203 |
Ref: Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. PMID: 19016023 |
Ref: Intraoperative radiotherapy for locally advanced rectal cancer. PMID: 21152229 |
Ref: Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer. PMID: 21218606 |
Ref: Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer. PMID: 22014952 Ref: MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. PMID: 23167930 |
Ref: (1)(8)F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes. PMID: 23436067 |
Ref: Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. PMID: 24606849 Ref: Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery. PMID: 25008360 Ref: Prognostic implications of the number of retrieved lymph nodes of patients with rectal cancer treated with preoperative chemoradiotherapy. PMID: 25091834 |
Ref: Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy. PMID: 26040453 |
Ref: Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series. PMID: 26385572 Ref: Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. PMID: 27100991 |
Ref: Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. PMID: 27028350 Ref: Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. PMID: 27720702 Ref: Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer. PMID: 28476826 Ref: Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response. PMID: 28481852 Ref: Results of short term radiotherapy followed by radical surgery for rectal cancer: A long-term unicenter observational study. PMID: 28583726 Ref: Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. PMID: 28657814 |